Brief: Amoeba H1 Operating Loss Stable At 2.9 Million Euros

Amoeba SA

29/09/2022 17:20

Sept 29 (Reuters) - Amoeba SA  ALMIB.PA :
    * ANNONCE SES RÉSULTATS SEMESTRIELS 2022
    * H1 NET LOSS EUR 4.7 MILLION VERSUS LOSS EUR 4.2 MILLION
YEAR AGO
    * H1 OPERATING LOSS EUR 2.9 MILLION VERSUS LOSS EUR 2.9
MILLION
YEAR AGO
    * THE COMPANY'S FINANCIAL DEBT AMOUNTS TO €4.8 MILLION
    * OUTLOOK: IS PURSUING ITS PROJECT TO SET UP ITS FIRST
BIOCONTROL
PLANT
    * OUTLOOK: THIS PLANT WOULD BE LOCATED IN FRANCE AND SHOULD
BE
OPERATIONAL IN 2024
    * OUTLOOK : IT SHOULD REPRESENT AN INVESTMENT ESTIMATED
BETWEEN 15
AND 17 MILLION EUROS FOR WHICH AMOÉBA WILL HAVE TO SEEK NEW
FINANCING FROM THE Q4 OF 2022

Source text for Eikon:  urn:newsml:reuters.com:*:nNDL86zLYg
Further company coverage:  ALMIB.PA 
 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))